Pharmaceutical

Rafarma’s global pharmaceutical strategy at a glance

Nicosia, Cyprus, May 18, 2021 (GLOBE NEWSWIRE) – Rafarma Pharmaceuticals, Inc. OTC: (RAFA) is an international biotechnology and pharmaceutical company that combines research centers and modern pharmaceutical production that meets international GMP standards. Rafarma Pharmaceuticals has consolidated and is in the process of consolidating a number of industrial companies, the …

Read More »

Sermonix Pharmaceuticals Announces Breast Cancer Research

The article demonstrates the ability of lasofoxifene to inhibit primary tumor growth and reduce metastasis in mouse models, both as monotherapy and in combination with palbociclib Study results demonstrate the potential of lasofoxifene as a next-generation selective estrogen receptor modulator (SERM) with a clinical profile differentiated from other SERMs / …

Read More »

Algernon Pharmaceuticals Inc Receives Positive Feedback From U.S. Food and Drug Administration For Its DMT Stroke Program

The pharmaceutical company is researching AP-188 (N, N-Dimethyltryptamine or DMT), as part of a physiotherapy program for stroke rehabilitation. Algernon Pharmaceuticals Inc (CSE: AGN) (OTCQB: AGNPF) (FRA: AGW) said it has received positive feedback from the United States Food and Drug Administration (FDA) on its plans to investigate the use …

Read More »

Voyageur Pharmaceuticals Ltd. Announces Health Canada Approval and Issuance of 5th Product License for MultiXThick Barium X-ray Contrast

May 17, 2021 (Source) – Voyageur Pharmaceuticals Ltd. (TSXV: VM) (OTC: VYYRF) (the “Company” or “Traveler”) is pleased to announce that it has received approval from Health Canada (HC) for its fifth product, MultiXthick Barium Sulfate Suspension containing 105% w / v barium sulfate suspension for oral and rectal administration …

Read More »

Eloxx Pharmaceuticals Inc (ELOX) up 3.70% pre-market

Eloxx Pharmaceuticals Inc (Eloxx Pharmaceuticals Inc (ELOX) was up Monday morning, with the stock adding 3.70% pre-trade to 1.4. ELOX’s short-term technical score of 4 indicates that the stock has traded less bullish in the past month than 96% of the stocks in the market. In the biotech industry, which …

Read More »

Zynerba Pharmaceuticals announces podium and poster

DEVON, Pa., May 17, 2021 (GLOBE NEWSWIRE) – Zynerba Pharmaceuticals, Inc. (Nasdaq: ZYNE), a leader in innovative transdermal transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders, today announced an oral podium presentation and poster presentation at the Virtual ISPOR 2021 conference which will take place May 17-20, 2021. Podium …

Read More »